Study guide

Optic-disc examination and documentation

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

Optic-disc examination and documentation

Key Takeaways Explain This Topic AI

Disc size influences cup interpretation, so a large cup alone does not establish glaucoma.

Focal rim loss, haemorrhage and longitudinal change need correlation with function.

Pallor disproportionate to cupping or an atypical field warrants a nonglaucomatous differential.

Last updated: October 2026

Glaucomatous optic neuropathy is characterized by progressive, irreversible loss of retinal ganglion cells (RGCs) and their axons, accompanied by morphological changes at the optic nerve head (cupping) and characteristic visual field defects. The modern clinical paradigm mandates a dual approach: high-resolution structural assessment of the optic disc and retinal nerve fibre layer (via clinical slit-lamp biomicroscopy and Spectral-Domain Optical Coherence Tomography) coupled with rigorous functional testing via Standard Automated Perimetry (SAP). Correlating structure and function is essential for the European Board of Ophthalmology Diploma (EBOD) examination.

1. Clinical Examination of the Optic Nerve Head (ONH)

The human optic nerve contains approximately 1.0 to 1.2 × 10 6 1.0\text{ to }1.2 \times 10^6 1.0 to 1.2 × 1 0 6 axons originating from retinal ganglion cells. These unmyelinated axons converge at the optic disc, turn 90 ∘ 90^\circ 9 0 ∘ posteriorly, exit the globe through the fenestrated collagen sheets of the lamina cribrosa, and become myelinated by oligodendrocytes posterior to the scleral ring of Elschnig.

Clinical Optic Disc Sizing

Accurate disc sizing is the indispensable first step in clinical evaluation because the physiological cup diameter correlates directly with the overall scleral canal area:

Measurement Technique: The vertical diameter of the optic disc is measured at the slit lamp using a high-magnification fundus lens (e.g., 60D, 78D, or 90D) with a thin vertical slit beam aligned between the inner margins of the white scleral ring of Elschnig.

Lens Correction Factors:

60D Lens: Correction factor = 1.0 × 1.0\times 1.0 × (slit length on the scale equals true vertical disc diameter).

78D Lens: Correction factor = 1.1 × 1.1\times 1.1 × (multiply measured slit height by 1.1 1.1 1.1 ).

90D Lens: Correction factor = 1.3 × 1.3\times 1.3 × (multiply measured slit height by 1.3 1.3 1.3 ).

Volk SuperField: Correction factor = 1.3 × 1.3\times 1.3 × .

Disc Size Categorization:

Small Disc (Micropapilla): Vertical diameter < 1.5 mm < 1.5\text{ mm} < 1.5 mm . Because axons are crowded through a tiny scleral canal, the physiological cup is tiny or absent (cup-to-disc ratio 0.1 – 0.2 0.1–0.2 0.1–0.2 ). In micropapillae, significant glaucomatous axonal loss can occur with a cup-to-disc ratio of only 0.4 – 0.5 0.4–0.5 0.4–0.5 , masquerading as a normal disc ( pseudonormal disc ).

Average Disc: Vertical diameter 1.5 to 1.9 mm 1.5\text{ to }1.9\text{ mm} 1.5 to 1.9 mm (population mean ≈ 1.8 mm \approx 1.8\text{ mm} ≈ 1.8 mm ).

Large Disc (Megalopapilla): Vertical diameter > 2.0 mm > 2.0\text{ mm} > 2.0 mm . A large scleral canal spreads axons thinly across a broad circumference, yielding a large physiological cup ( 0.6 – 0.8 0.6–0.8 0.6–0.8 ) in an entirely healthy eye ( pseudoglaucoma ).

The ISNT Rule & Structural Vulnerability

In healthy, non-glaucomatous optic discs, the thickness of the neuroretinal rim obeys a strict anatomical hierarchy known as the ISNT rule : I n f e r i o r ≥ S u p e r i o r ≥ N a s a l ≥ T e m p o r a l \mathbf{Inferior} \ge \mathbf{Superior} \ge \mathbf{Nasal} \ge \mathbf{Temporal} Inferior ≥ Superior ≥ Nasal ≥ Temporal

Biomechanical Vulnerability of the Lamina Cribrosa: Histological studies demonstrate that the laminar connective tissue plates are structurally thinnest and possess the largest pore apertures at the superior and inferior poles . Consequently, these vertical regions have the least mechanical collagen support for exiting axons and capillary microvessels.

ISNT rule: Inferior, superior, nasal and temporal rim thickness often follows this order in healthy discs, but normal variation is substantial. A violation can raise suspicion; it does not independently diagnose glaucoma. Disc size, tilt, myopia, focal loss and serial change matter.

Structural Signs of Glaucoma

Structural Biomarker Pathophysiological Mechanism Clinical Appearance & Diagnostic Significance

Focal Rim Notching Localized apoptosis of a discrete retinal ganglion cell axon bundle. Complete focal loss of neuroretinal rim tissue extending to the scleral ring, most common at the inferotemporal disc margin ( 70 % 70\% 70% ) followed by superotemporal ( 25 % 25\% 25% ).

Vertical Cup Elongation Preferential destruction of superior and inferior laminar axons. Vertical cup-to-disc ratio (VCDR) expands faster than horizontal ratio. Cup asymmetry in discs of similar size raises suspicion and needs correlation with rim, RNFL and functional findings; it is not assigned a universal specificity.

Drance Haemorrhage Microvascular ischemic disruption or mechanical traction at the cribriform plate. Splinter- or flame-shaped haemorrhage situated in the superficial pRNFL at or crossing the neuroretinal rim. Most frequent inferotemporally; risk marker prompting reassessment, without proving progression ; highly prevalent in Normal-Tension Glaucoma (NTG) .

Bared Circumlinear Vessels Retraction of neuroretinal rim tissue away from pre-existing blood vessels. Circumlinear surface vessel that originally ran along the inner rim border is left isolated ("bared"), suspended across the excavated cup without underlying tissue contact.

Bayoneting of Vessels Extreme undercutting of the neuroretinal rim margin. A blood vessel diving sharply backward into an excavated cup, disappearing beneath the overhanging rim edge, and re-emerging on the lamina cribrosa with a double bend like a bayonet.

Laminar Dot Sign Loss of overlying neural tissue reveals the bare collagenous lamina cribrosa. Grey, rounded fenestrations (pores) exposed at the floor of an excavated cup.

Peripapillary Chorioretinal Atrophy (PPA): Alpha vs. Beta Zones

Peripapillary atrophy is subdivided into two distinct anatomical concentric zones:

Alpha ( α \alpha α ) Zone: The outer, peripheral zone. Exhibits irregular hyper- and hypopigmentation of the retinal pigment epithelium (RPE). It is present in both healthy individuals and glaucoma patients and carries no specific diagnostic value.

Beta ( β \beta β ) Zone: The inner zone situated directly adjacent to the scleral ring of Elschnig. Characterized by complete atrophy of both the RPE and the choriocapillaris , leaving only bare white sclera and large underlying choroidal vessels clearly visible.

Clinical Significance: The width and circumferential extent of the β \beta β -zone correlate strongly with the severity and rate of glaucomatous progression. Furthermore, the location of the largest β \beta β -zone sector aligns topographically with the quadrant of greatest neuroretinal rim loss and visual field deficit.